Nanox Signs MSaaS Agreement for the Deployment of 1,000 Nanox Systems in Nigeria
According to the agreement and subject to regulatory approval, EiLEENO Pharma will commit to a minimum annual service fee to Nanox.
- According to the agreement and subject to regulatory approval, EiLEENO Pharma will commit to a minimum annual service fee to Nanox.
- The agreement has an initial term of four years and is renewable for an additional term of four years with both parties mutual consent.
- "We are very excited to sign the unique MSaaS agreement with NANOX, to deploy medical imaging systems and ensure services for healthcare facilities across the country," said Edward Egede, Managing Director and CEO of EiLEENO Pharma.
- Medical imaging systems are an important early-detection tool that Nanox believes are key to increasing early treatment, improving health outcomes, and ultimately saving lives.